PSTV
PLUS THERAPEUTICS, Inc. Common Stock
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$0.24
+$0.00
(+0.67%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $43.18M | EPS (ttm) | $-0.96 | Current Price | $0.24 |
| Enterprise Value | $22.87M | Forward EPS | $-0.15 | Previous Close | $0.24 |
| P/E Ratio | - | ROA | -65.58% | 52W High | $2.31 |
| Forward P/E | -1.65 | ROE | - | 52W Low | $0.16 |
| PEG Ratio | - | Gross Margin | -45.00% | 50 Day Avg | $0.50 |
| P/S Ratio | 8.21 | Operating Margin | -320.83% | 200 Day Avg | $0.51 |
| P/B Ratio | 6.37 | Profit Margin | - | Volume | 5.54M |
| EV/EBITDA | -1.76 | Current Ratio | 1.29 | Avg Volume | 9.80M |
| EV/Sales | 4.35 | Quick Ratio | 1.22 | Beta | 0.85 |
| Employees | 21.00 | Debt/Equity | 127.05 | Shares Outstanding | 178.37M |
| Sector | Healthcare | Total Debt | $6.42M | Float Shares | 127.33M |
| Industry | Biotechnology | Total Cash | $16.60M | Short Float | 6.37% |
| Optionable | No | Cash/Share | $0.12 | Short Ratio | 1.23 |
| Dividend Yield | - | Book Value/Share | $0.04 | % Held by Insiders | 1.15% |
| Target Price | $5.50 | Revenue (TTM) | $5.26M | % Held by Institutions | 10.14% |